APA

Motomura K., Ishitobi M., Komoike Y., Koyama H., Nagase H., Inaji H. & Noguchi S. (20110128). Expression of estrogen receptor beta and phosphorylation of estrogen receptor alpha serine 167 correlate with progression-free survival in patients with metastatic breast cancer treated with aromatase inhibitors. : Oncology.

Chicago

Motomura Kazuyoshi, Ishitobi Makoto, Komoike Yoshifumi, Koyama Hiroki, Nagase Hideki, Inaji Hideo and Noguchi Shinzaburo. 20110128. Expression of estrogen receptor beta and phosphorylation of estrogen receptor alpha serine 167 correlate with progression-free survival in patients with metastatic breast cancer treated with aromatase inhibitors. : Oncology.

Harvard

Motomura K., Ishitobi M., Komoike Y., Koyama H., Nagase H., Inaji H. and Noguchi S. (20110128). Expression of estrogen receptor beta and phosphorylation of estrogen receptor alpha serine 167 correlate with progression-free survival in patients with metastatic breast cancer treated with aromatase inhibitors. : Oncology.

MLA

Motomura Kazuyoshi, Ishitobi Makoto, Komoike Yoshifumi, Koyama Hiroki, Nagase Hideki, Inaji Hideo and Noguchi Shinzaburo. Expression of estrogen receptor beta and phosphorylation of estrogen receptor alpha serine 167 correlate with progression-free survival in patients with metastatic breast cancer treated with aromatase inhibitors. : Oncology. 20110128.